Ignis Therapeutics

Exploring the power of neuroscience, igniting the possibilities of life

Shanghai, China · Founded 2020 · $180.0M raised

Headquarters
Shanghai
Employees
51–200
Founded
2020
Business Model
B2B
Total Funding
$180.0M
Last Round
$180.0M Series AJun 2021
Rounds
1

About

Ignis Therapeutics is a Shanghai-based biotech company founded in 2020 that develops therapies for central nervous system diseases, including epilepsy, Parkinson's disease, major depressive disorder, and Alzheimer's disease. The company combines licensed-in products, in-house R&D, and mature therapeutics to build a pipeline of more than 20 programs, and has raised $185 million in a Series A financing round, a record for China's biopharma sector at the time. Ignis has formed strategic partnerships with SK Biopharmaceuticals and NeuroSigma to advance CNS treatments in China.

Summary

Ignis Therapeutics is a Biotech company based in Shanghai, China, founded in 2020. It has raised $180.0M in total across 1 round, most recently a $180.0M Series A round in Jun 2021. Investors include 6 Dimensions Capital, Ruentex Group and KB Investment.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AJun 2021
$180.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ignis Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/ignis-therapeutics"><img src="https://indexed.vc/api/badge/company/ignis-therapeutics" alt="Ignis Therapeutics on Indexed.vc" width="260" height="76" /></a>